Amazon (NASDAQ: AMZN) remains a top pick for Goldman Sachs as the investment bank reaffirmed its Buy rating with a $290 price target following the company's annual AWS re:Invent conference on December 5.
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Canadian PM Mark Carney expected to meet President Donald Trump at FIFA World Cup draw amid stalled trade talks and ongoing tariff tensions affecting Canada's GDP.
Boliden AB (publ) (BDNNY) Discusses 2026 Operational Guidance and Outlook for Mines and Smelters Transcript
Cushman & Wakefield Limited (CWK) Cushman & Wakefield plc - Analyst/Investor Day Transcript
ALRM, MU and GLDD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on Dec.5, 2025.
Over the past 12 months, the software industry has fixated on a singular, daunting question: “Will AI eliminate the Database?”
TSMC is the linchpin of global advanced chip manufacturing, supplying industry leaders across AI and smartphones. Demand for TSM's advanced-node capacity far exceeds supply, with key customers like Apple and Nvidia securing future production. TSM plans 3–10% price hikes in 2026, likely driving profit margins above 45% and supporting multiple expansions.
RDN, AEO and EXPD made it to the Zacks Rank #1 (Strong Buy) income stocks list on Dec. 5, 2025.
Foxconn, also known as Hon Hai, has reported a 26% year-on-year revenue increase. The company is the world's largest contract electronics manufacturer, assembling Apple's iPhone and making the servers that hold chips in data centers.
SPDR Portfolio Emerging Markets ETF tracks the S&P Emerging BMI Index, emphasizing China, Taiwan, and India, with a 0.07% fee. SPEM offers broad exposure with over 3,000 holdings, a 2.5% dividend yield, and trades at 15x earnings and 2x book value. The ETF is overweight dominant Asian emerging markets by about 10 percentage points versus the MSCI EM Index.
HRTG stock surges 136% YTD, fueled by strong underwriting, pricing discipline, and reinsurance-driven margin gains.
Does Salesforce's new momentum have the stock on track for a comeback?
America's biggest retailer is growing quickly in e-commerce, and it might advance more as it moves to Nasdaq.
Constellation Brands remains a sell as business fundamentals deteriorate, with no credible signs of stabilization or turnaround. STZ's Q1 2026 saw organic sales down 8% and operating income down 13%, with beer volumes falling 8.7% and the wine segment in operating loss. Despite a low P/E ratio, STZ's high EV/FCF multiple (25–26x) is unjustified for a shrinking, structurally challenged business.
iShares A.I. Innovation and Tech Active ETF (BAI) is rated a Buy for its high-conviction, selective exposure to AI leaders and service integrators. BAI outperforms broad passive ETFs in AI bull markets but exhibits sharper drawdowns; its active approach favors higher risk and higher return potential. Compared to CHAT, BAI is more concentrated in US hyperscalers and infrastructure, offering defensiveness in consolidating or correcting markets.
Saab and Airbus are discussing co-operation on unmanned warplane technology, senior executives of the companies told Reuters, a move highlighting surging interest in drones and evolving alliances in Europe's fractured defence industry.
Brookfield Renewable Corporation offers superior total return and simplicity versus Brookfield Renewable Partners L.P., despite a lower yield. BEPC benefits from capital recycling, a diversified renewable portfolio, and strong contracted cash flows, targeting 10%+ FFO and 5-9% distribution growth. Recent performance shows BEPC outpacing BEP, with 30% vs. 10.3% total return over the past year, despite a 3.6% yield versus BEP's 5.2%.
One year ago, while Nvidia's (NASDAQ:NVDA) AI-driven ascent was in full swing, we recommended reducing positions in the GPU leader and shifting towards undervalued Intel (NASDAQ:INTC)—a contrarian investment based on potential rebounds in the semiconductor sector.
Here are three stocks with buy rank and strong value characteristics for investors to consider today, Dec. 5:
Hims & Hers Health expands into Canada via Livewell acquisition, targeting a large, underserved weight-loss market. Canadian entry leverages local leadership and expertise, aiming to replicate successful European expansion and accelerate subscriber growth. GLP-1 weight-loss treatments drive revenue potential but introduce margin pressure and cost volatility, creating both opportunity and structural risk.
I upgrade Rivian Automotive to a strong buy heading into 2026, mainly driven by improving margins, favorable policy tailwinds, and a nice catalyst ahead. Q3 beat Street estimates ($1.56B revenue vs. $1.51B; -$0.65 adj. loss/share vs. -$0.71), and management reiterated FY2025 delivery/EBITDA/capex guidance despite weaker Q4 demand expectations. Software and services, comprising 27% of Q3 revenue, enabled positive gross profit despite automotive segment losses (-$130M).
Ascendis Pharma has achieved operational profitability, driven by YORVIPATH's rapid adoption and strong Q3 2025 revenues of €213.6 million. ASND's robust cash position (€539 million) and self-sustaining business model eliminate near-term dilution risk and support continued pipeline investment. TransCon platform advances, including SKYTROFA label expansion and TransCon CNP, offer significant growth opportunities, with regulatory risk now mostly administrative.
Shares of the company were down 4.5% in premarket trading after global websites went down and Cloudflare said it was investigating.
Sila Realty Trust remains a Buy, offering a nearly 7% dividend yield and trading at a substantial discount to intrinsic value. SILA's Q3 report beat expectations, with strong financial positioning, a $43M acquisition pipeline, and no debt maturities until 2027, coming at a 4.8% average interest rate. The REIT's ramp-up is supported by accelerated yet disciplined leverage management, targeting a 4.5x–5.5x net debt/EBITDA ratio, meaning they still have significant room to expand.
A potential artificial intelligence bubble will deflate faster than past tech cycles but give way to an even stronger rebound as corporate adoption catches up with infrastructure spending, the head of Japanese IT company NTT DATA Inc. said.
Hovnanian Enterprises remains a 'strong buy' despite a 22.5% share price drop driven by weak Q4 results and soft near-term guidance. HOV trades at compelling mid-single-digit cash flow multiples, making it the cheapest among peers on this metric. Management is proactively reducing debt, restructuring maturities, and focusing on land with higher embedded incentives to protect margins.
IDMO is a momentum ETF that seeks to represent developed market stocks excluding the U.S. In my opinion, it interfaces well within a diversified portfolio; almost 50% of the portfolio is in financials, which is an anomaly compared to classic global ETFs. It seems to have had competitive performance compared to other ETFs such as EFA and other ex. US ETFs.
The Russell 2000 Dividend Growers ETF offers a defensive, income-focused small-cap strategy with a strong tilt toward financials, utilities, and industrials. SMDV trades at an 11% P/E discount to the Russell 2000, boasts a 2.6% yield, and demonstrates superior profitability metrics but lags in sales growth. Performance has consistently trailed the Russell 2000 and peers, with limited upside capture in rallies.
Initial estimates indicate the reservoirs west of Norway could contain 30 million to 110 million barrels of recoverable oil equivalent.